Bristol-Myers Squibb Drug List

S.No. Company Name Short Description No of Drugs Company Drug Price Action
1 Bristol-Myers SquibbBristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.675.00BUYYour Query
S.No. Updated On Drug Price in USD Action
1Jun, 2020Baraclude Drug Sales & Forecast

BMS drug Baraclude was first approved in March 2005 and subsequent approvals in Japan and the five major EU markets (France, Germany, Italy, Spain, and th....

15.00READBUY Your Query
2Jun, 2020Eliquis Drug Sales & Forecast

BMS drug Eliquis (apixaban) is an oral Factor Xa inhibitor, targeted at stroke prevention in adult patients with NVAF and the prevention and treatment of ....

15.00READBUY Your Query
3Jun, 2020Empliciti Drug Sales & Forecast

BMS and AbbVie jointly develop and commercialize Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma. Both parties participat....

15.00READBUY Your Query
4Jun, 2020Opdivo/Yervoy Drug Sales & Forecast

Opdivo is a programmed death-1 (PD-1) immune checkpoint inhibitor that is designed to uniquely harness the body’s own immune system to help restore anti....

15.00READBUY Your Query
5Jun, 2020Orencia Drug Sales & Forecast

BMS drug Orencia (abatacept), a biological product, is a fusion protein indicated for adult patients with moderately to severely active rheumatoid arthrit....

15.00READBUY Your Query
6Jun, 2020Sprycel Drug Sales & Forecast

BMS drug Sprycel (dasatinib) is an oral inhibitor of multiple tyrosine kinase indicated for the first-line treatment of patients with Philadelphia chromos....

15.00READBUY Your Query